Ann D. Rhoads is Director at QuidelOrtho Corp (QDEL). They have made 7 open-market trades across 5 companies since 2011, most recently 2026-06-04.
CIK 0001250252
4 open-market purchases totalling $322K since 2011, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ZGNX | 469,980 | $12.5M |
| FTSV | 37,414 | $3.6M |
| GMED | 40,384 | $3.5M |
| NVLS | 35,000 | $336K |
| QDEL | 23,257 | $334K |
| RPTX | 4,000 | $11K |
| IRIX | 5,690 | $4K |
| Total | $20.3M |
Shares reported on the most recent Form 4, priced at the 2026-06-08 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| QDEL | BUY | 2025-12-10 | 2025-12-10 | $28.28 | $21K | +3.1% | +16.3% | -33.3% |
| GMED | SELL · 10b5-1 | 2025-11-07 | 2025-11-10 | $81.80 | $818K | -4.3% | +2.1% | +1.8% |
| GMED | SELL · 10b5-1 | 2025-09-15 | 2025-09-16 | $58.46 | $585K | -3.6% | +1.4% | +49.7% |
| GMED | SELL · 10b5-1 | 2025-02-28 | 2025-03-04 | $78.68 | $590K | -8.9% | -7.7% | -24.4% |
| GMED | SELL | 2024-09-13 | 2024-09-17 | $70.36 | $1.1M | +2.3% | +7.1% | +18.4% |
| RPTX | BUY | 2020-06-23 | 2020-06-25 | $20.00 | $80K | -14.8% | -34.0% | -0.8% |
| FTSV | SELL | 2020-04-01 | 2020-04-03 | $95.43 | $367K | N/A | N/A | N/A |
| ZGNX | SELL | 2014-06-02 | 2014-06-04 | $2.09 | $40K | -27.8% | -4.8% | -4.8% |
| ZGNX | BUY | 2012-12-12 | 2012-12-12 | $1.19 | $21K | -27.8% | -4.8% | -4.8% |
| ZGNX | BUY | 2011-09-21 | 2011-09-21 | $2.00 | $200K | -27.8% | -4.8% | -4.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.